instrument_fundamentals
date | Close | change | Change (%) | instr__open | High | Low |
---|
instr__news

Investors Purchase High Volume of Gilead Sciences Call Options (NASDAQ:GILD)

Frank Rimerman Advisors LLC Acquires 232 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) is Globeflex Capital L P's 2nd Largest Position

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Acquired by Lbp Am Sa

Integras Partners LLC Makes New Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences Sees Unusually High Options Volume (NASDAQ:GILD)

Calls of the Day: Shake Shack, Starbucks, 3M, Gilead Sciences, Eli Lilly

Lbp Am Sa Grows Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Integras Partners LLC Buys Shares of 31,045 Gilead Sciences, Inc. (NASDAQ:GILD)

Avantax Advisory Services Inc. Lowers Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences - Leader in HIV Medicines

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by Farther Finance Advisors LLC

34,912 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Bought by JPL Wealth Management LLC

Erste Asset Management GmbH Sells 18,055 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Acquired by Connor Clark & Lunn Investment Management Ltd.

Avantax Advisory Services Inc. Lowers Position in Gilead Sciences, Inc. (NASDAQ:GILD)

This company stands out for investors looking to invest in US markets

A rare Nasdaq gem with consistent returns across time horizons

Once-Yearly Lenacapavir PrEP a Safe, Promising Alternative to Twice-Yearly Dosing

Insider Selling: Gilead Sciences, Inc. (NASDAQ:GILD) CFO Sells 17,929 Shares of Stock

Gilead Sciences - Women's History Month Celebrated With Its Team

Why Gilead Sciences, Inc. (GILD) is the Best Pharma Stock to Buy According to Hedge Funds

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Acquired by Achmea Investment Management B.V.

Vestcor Inc Has $20.16 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Swiss National Bank

Wealthfront Advisers LLC Lowers Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Citizens Financial Group Inc. RI Purchases 3,706 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Follow the Leader: 2 Biopharma Stocks Showing Relative Strength in 2025 - March 13, 2025 - Zacks.com

Analyst Says Gilead Sciences (GILD) is a 'Big Liquid' Stock You Should Pay Attention To - Insider Monkey

Gilead Sciences (NASDAQ:GILD) Given New $130.00 Price Target at Morgan Stanley

Gilead's capsid revolution meets our capsid solutions: Sino Biological - Engineering the tools to outsmart HIV

Gilead Sciences' annual HIV prevention injection shows promise in clinical trial, Lancet study reveals

Great Lakes Advisors LLC Has $90.63 Million Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Stake Raised by HighTower Advisors LLC
Gilead Sciences (NASDAQ:GILD) Is Increasing Its Dividend To $0.79

Natural Investments LLC Makes New Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

Yearly Injection To Protect Against HIV? Gilead's Lenacapavir Shows Promise In Clinical Trial

Personal CFO Solutions LLC Buys New Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Edgestream Partners L.P. Sells 14,668 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Proficio Capital Partners LLC Acquires Shares of 339,489 Gilead Sciences, Inc. (NASDAQ:GILD)

Bernstein Reaffirms Their Buy Rating on Gilead Sciences (GILD) | Markets Insider

GILD Data on Once-Yearly Lenacapavir for HIV Prevention Positive - March 12, 2025 - Zacks.com

The Zacks Analyst Blog Highlights Exelon, Gilead Sciences, Plains All American Pipeline, Sportradar and Cintas

Gilead Presents Encouraging Long-term Data For Biktarvy In People With HIV And HBV Coinfection

Gilead's Phase 1 Data Shows Promise For Once-Yearly Lenacapavir In HIV Prevention

Top 10 Stocks Wall Street is Discussing

Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, Morgan Stanley Analyst Says

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Dearborn Partners LLC

Channing Capital Management LLC Cuts Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

NVO Stock Down 9% as CagriSema Misses Target in Second Obesity Study - March 11, 2025 - Zacks.com

First Clinical Data for Gilead's Investigational Once-Yearly Lenacapavir for HIV Prevention Presented at CROI 2025 and Published in The Lancet - Drugs.com MedNews

These 3 Attractive Stocks Keep Cruising Higher - March 11, 2025 - Zacks.com

Buy 5 Non-Tech High-Flying Nasdaq Stocks Amid Index's Recent Bloodbath - March 11, 2025 - Zacks.com

Gilead Sciences (NASDAQ:GILD) Hits New 12-Month High - Should You Buy?

Daiwa Securities Group Inc. Acquires 39,700 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Ruffer LLP Makes New $6.50 Million Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

AlphaQuest LLC Raises Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

M. Kulyk & Associates LLC Sells 11,801 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Jackson Hole Capital Partners LLC Raises Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Investors Research Corp Has $1.07 Million Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Ranch Capital Advisors Inc. Purchases 7,153 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Daiwa Securities Group Inc. Raises Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Argentarii LLC Buys Shares of 3,293 Gilead Sciences, Inc. (NASDAQ:GILD)

Bank Julius Baer & Co. Ltd Zurich Sells 36,080 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Zacks Investment Ideas feature highlights: Gilead Sciences and Johnson & Johnson - March 10, 2025 - Zacks.com

LLY/INCY Olumiant Shows Superior Efficacy in Pediatric Alopecia Study - March 10, 2025 - Zacks.com

Is Gilead Sciences (GILD) Stock Outpacing Its Medical Peers This Year? - March 10, 2025 - Zacks.com

EC Approves Bristol Myers' Opdivo Plus Yervoy for First-Line HCC

Ruffer LLP Invests $6.50 Million in Gilead Sciences, Inc. (NASDAQ:GILD)

OFI Invest Asset Management Purchases New Shares in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Stake Raised by Dorsey & Whitney Trust CO LLC

Lifeworks Advisors LLC Raises Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

River Global Investors LLP Sells 7,892 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Intellectus Partners LLC Sells 6,025 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Amundi

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Bought by Aviance Capital Partners LLC

Ashton Thomas Private Wealth LLC Purchases 932 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Callan Family Office LLC Takes $2.83 Million Position in Gilead Sciences, Inc. (NASDAQ:GILD)

3,919 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Bought by Destination Wealth Management

Buy Gilead Sciences (GILD) Stock at 52-Week Highs? - March 8, 2025 - Zacks.com

Krystal Biotech Rises 15.8% in a Month: Should You Buy Now or Wait? - March 8, 2025 - Zacks.com

Enabling sensitive and precise detection of ctDNA through somatic copy number aberrations in breast cancer

Inceptionr LLC Grows Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Atria Investments Inc Sells 15,262 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Nivolumab plus chemotherapy or ipilimumab in gastroesophageal cancer: exploratory biomarker analyses of a randomized phase 3 trial

Buy Gilead Sciences (GILD) Stock at 52-Week Highs? - March 7, 2025 - Zacks.com

3 Healthcare Stocks With Strong EPS Growth Potential to Buy in 2025 - March 7, 2025 - Zacks.com

Bank of America Boosts Gilead Sciences (NASDAQ:GILD) Price Target to $126.00

Assetmark Inc. Sells 1,880,494 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Wells Fargo & Company Increases Gilead Sciences (NASDAQ:GILD) Price Target to $140.00

Candriam S.C.A. Has $159.18 Million Stake in Gilead Sciences, Inc. (NASDAQ:GILD)
Latest news

Bank of Japan to discuss economic risks associated with the Trump trade war

Dow Jones futures decline following a Nasdaq rally led by Tesla and Nvidia

Morning Note: UK GDP Data, NVDA Stock Dip, & CAD Weakness Amid Oil Decline

Stock market today: Dow and S&P 500 Remain Steady over Calm CPI Report